Prospective study of immunomodulation with GM-CSF, IL-2, and rituximab following autologous stem cell transplant (SCT) in patients with relapsed lymphomas.

被引：0
|
作者：
Smith, SM
Grinblatt, DL
Gajewski, T
Harlin, H
Welborne, K
Conner, K
Larson, RA
Rich, E
Odenike, O
Zimmerman, T
van Besien, K
机构：
[1] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[2] Northwestern Univ, Evanston, IL USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.918.918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
918
引用
收藏
页码：263A / 263A
页数：1
相关论文
共 50 条
  • [41] Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant
    Sureda, Anna
    Younes, Anas
    Ben-Yehuda, Dina
    Ong, Tee-Chuan
    Kaufman, Jonathan L.
    Le Corre, Christophe
    Gallagher, Jennifer
    Shen, Angela
    Engert, Andreas
    BLOOD, 2010, 116 (21) : 187 - 187
  • [42] Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).
    Berger, Elizabeth
    Seet, Christopher
    Parthasarathy, Mala
    Rodriguez, Tulio
    Smith, Scott E.
    Toor, Amir
    Lee, Mary
    Petrowsky, Cecilia
    Fox-Geiman, Mary
    Stiff, Patrick
    BLOOD, 2009, 114 (22) : 1250 - 1251
  • [43] Immunological autologous stem cell graft engineering using combination G-CSF and aldesleukin (IL-2) in patients with non-Hodgkin's lymphoma
    Micallef, IN
    Markovic, SN
    Geyer, S
    Porrata, LF
    Ansell, SM
    Inwards, DJ
    Gastineau, DA
    Padley, DJ
    Armstrong, AS
    Litzow, MR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 8 - 8
  • [44] HEMATOPOIETIC RECOVERY FOLLOWING HIGH-DOSE COMBINED ALKYLATING-AGENT CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT IN PATIENTS IN PHASE-I CLINICAL-TRIALS OF COLONY-STIMULATING FACTORS - G-CSF, GM-CSF, IL-1, IL-2, M-CSF
    LAUGHLIN, MJ
    KIRKPATRICK, G
    SABISTON, N
    PETERS, W
    KURTZBERG, J
    ANNALS OF HEMATOLOGY, 1993, 67 (06) : 267 - 276
  • [45] A randomized prospective study of peripheral blood stem cell (PBSC) mobilization with cyclophosphamide (CTX) in combination with G-CSF, GM-CSF, or sequential GM-CSF followed by G-CSF, in non-hodgkin's lymphoma (NHL) patients: Co-mobilization of dendritic cells and NK cells.
    Gazitt, Y
    Fey, V
    Shaughnessy, P
    Devore, P
    BLOOD, 1999, 94 (10) : 637A - 637A
  • [46] Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study
    Redondo, Alba M.
    Pomares, Helena
    Vidal, Maria J.
    Pascual, Maria J.
    Quereda, Belen
    Sancho, Juan M.
    Polo, Marta
    Lopez, Javier
    Conde, Eulogio
    Jarque, Isidro
    Alonso, Natalia
    Ramirez, Maria J.
    Fernandez, Pascual
    Sayas, Maria J.
    Requena, Maria J.
    Salar, Antonio
    Gonzalez, Jose D.
    Gonzalez-Barca, Eva
    Arranz, Reyes
    Caballero, Dolores
    Martin, Alejandro
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) : 668 - 674
  • [47] Rituximab and Interleukin 2 (IL2) as treatment for CD20+non-Hodgkin's lymphoma (NHL) following autologous peripheral blood stem cell transplant (ASCT).
    Holmberg, LA
    Maloney, DG
    Bensinger, WI
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 566S - 566S
  • [48] A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931
    Ozkaynak, M. Fevzi
    Gilman, Andrew L.
    London, Wendy B.
    Naranjo, Arlene
    Diccianni, Mitchell B.
    Tenney, Sheena C.
    Smith, Malcolm
    Messer, Karen S.
    Seeger, Robert
    Reynolds, C. Patrick
    Smith, L. Mary
    Shulkin, Barry L.
    Parisi, Marguerite
    Maris, John M.
    Park, Julie R.
    Sondel, Paul M.
    Yu, Alice L.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [49] Donor lymphocyte infusions and IL-2 as adaptive immunotherapy for patients with advanced malignancies undergoing high-dose chemotherapy and autologous stem cell transplant.
    Raptis, A
    Ballester, O
    Grutsch, JF
    Williams, S
    Tan, B
    Wilcox, P
    Payne, M
    Braun, B
    BLOOD, 2002, 100 (11) : 452B - 452B
  • [50] Maintenance therapy with subcutaneous (SC) low dose recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) for breast cancer patients following autologous stem cell transplantation (ASCT).
    Nagler, A
    Ackerstein, A
    Or, R
    Varadi, G
    Slavin, S
    BLOOD, 1999, 94 (10) : 379B - 379B
12345